- 1、本文档共6页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
MS Contin treatment of pain in 82 cases of dose distribution analysis of
PAGE \* MERGEFORMAT 6
MS Contin treatment of pain in 82 cases of dose distribution analysis of
[Keywords:] MS Contin dose distribution characteristics of pain
Treatment of patients with cancer pain is increasingly being everyone’s attention, control of cancer pain is an important clinical oncology one of the elements. Currently existing cancer patients around the world about 140 million, of which 30% ~ 60% accompanied by varying degrees of pain, and nearly half are not limited control, directly affecting the quality of life of patients, so this study application of MS Contin Treatment 82 cases of advanced cancer pain, results were satisfactory. Are reported below.
1 Materials and Methods
1.1 General information select from April 2005 to April 2007, Zhejiang Xiaoshan hospital during the initial use of MS Contin treatment of cancer pain in advanced cancer patients are diagnosed as malignant by pathology, continuous regulate the use of MS Contin drug therapy ≥ 4 weeks. 43 cases were males, 39 females, aged 45 to 70 years old, mean age (65.28 ± 4.63) years of age. Visceral pain in cases of 24 cases, 12 cases of physical pain, bone pain and 12 cases, 7 cases of neuropathic pain, mixed pain 27.
1.2 Methods moderate pain group first give MS Contin (Di Meng from Beijing Pharmaceutical Co., Ltd. Production) 10mg, oral once every 12 hours, dose-titration until pain control in the digital Assessment Act (numerical rating scale, NRS) ≤ 3; severe pain group was given MS Contin 20mg orally once every 12 hours, dose-titration until pain control in NRS ≤ 3. Through the NRS to assess their pain intensity, comparative observation of MS Contin for moderate pain (NRS 4 ~ 7,36 cases) and severe pain (NRS 8 ~ 10,46 cases) required daily dosage, different types of daily pain and different doses of MS Contin daily dose of the incidence of adverse reactions.
1.3 statistical methods using SPSS 11.0 statistical software. Measurement data using mean ± standard deviation (■ ),
您可能关注的文档
- Motivate your boss.doc
- Motion Strategic Brand Management.doc
- Motion sickness in rat plasma levels of calcitonin gene-related peptide changes in.doc
- Mother to child transmission of hepatitis B blockade on the clinical observation.doc
- Motion Paging - wading river feelings.doc
- Mother to child transmission of hepatitis B virus blocking the nursing intervention_0.doc
- Motivate your dealer.doc
- Moto does the fault lie-.doc
- Motivate your employees.doc
- MOTO! Show is always hard to avoid.doc
- MS Contin treatment of severe pain in advanced cancer of 65 cases.doc
- MS Contin with transdermal fentanyl in the treatment of moderate to severe pain in the observation of.doc
- MSA after the tobacco marketing strategy.doc
- MSCT efficacy in the treatment of fatty liver of the quantitative role.doc
- MSCT diagnosis of costal cartilage injury.doc
- MSCT pulmonary angiography combined indirect method of lower extremity venous imaging techniques.doc
- Ms. Wine- Wine's new adventure.doc
- MSCT of the aortic aneurysm and joint evaluation of the heart.doc
- MS Contin anal cancer pain drug treatment for 60 Cases aged.doc
- MS Contin rectal cancer pain control in patients with advanced gastrointestinal cancer clinical observation of.doc
文档评论(0)